A Machine Learning and Bayesian Belief Network Approach to Predicting Cervical Cancer Risk: Implications for Risk Management
Journal of Multidisciplinary Healthcare · 2025-08 · Volume 18 · 5199-5211
DOI: 10.2147/jmdh.s524132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Multidisciplinary Healthcare, 2025-08. Verfasst von Khaled Toffaha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Management Science & Engineering, Khalifa University of Science & Technology, Abu Dhabi, United Arab Emirates. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Introduction
Cervical cancer remains a major global health challenge, necessitating enhanced risk stratification and early detection methodologies. This study proposes a comprehensive predictive framework for cervical cancer leveraging advanced machine learning (ML) algorithms and Bayesian Belief Networks (BBNs), illustrating the transformative role of digital technologies in healthcare and education within an increasingly digitized society.
Methods
A cohort of 858 patients was analyzed, addressing data challenges, including missing values, class imbalance, and nonlinear feature interactions, that frequently compromise the reliability of predictive modeling. Methodologically, this study integrated advanced data science approaches, including multiple imputation, feature selection, and imbalance mitigation, advancing medical analytics to ensure robust model generalizability.
Results
High predictive performance was observed across different cervical cancer screening tests. The combined target ML model achieved an accuracy of 95.6%, an area under the receiver-operating characteristic curve (AUROC) of 0.958, and an F1-score of 0.945. The BBN, built upon the Bayesian Additive Regression Trees (BART) model, demonstrated a positive prediction rate (sensitivity) of 91.3% and a negative prediction rate (specificity) of 86.8%.
Discussion
These results validate the technical efficacy of the proposed framework and underscore its potential for integration into clinical decision-support systems. Beyond clinical applications, this research contributes to computational oncology by demonstrating the synergistic potential of combining probabilistic graphical models with ML techniques. The study highlights the critical role of interdisciplinary collaboration between clinical experts and data scientists in creating effective AI healthcare solutions. It also emphasizes the need for upskilling healthcare workers and optimizing healthcare delivery processes to fully realize the benefits of precision medicine.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Management Science & Engineering, Khalifa University of Science & Technology, Abu Dhabi, United Arab Emirates.
- Abu Dhabi Health Data Services, M42, Abu Dhabi, United Arab Emirates.
ORCID-Profile: Khaled Toffaha, Mecit Can Emre Simsekler, Michael A Kortt
Zitieren
APA
Toffaha, K., Simsekler, M. C. E., Sleptchenko, A., Kortt, M. A., & Bukasa, L. L. (2025). A Machine Learning and Bayesian Belief Network Approach to Predicting Cervical Cancer Risk: Implications for Risk Management. Journal of Multidisciplinary Healthcare, Volume 18, 5199-5211. https://doi.org/10.2147/jmdh.s524132
Vancouver
Toffaha K, Simsekler MCE, Sleptchenko A, Kortt MA, Bukasa LL. A Machine Learning and Bayesian Belief Network Approach to Predicting Cervical Cancer Risk: Implications for Risk Management. Journal of Multidisciplinary Healthcare. 2025;Volume 18:5199-5211. doi:10.2147/jmdh.s524132
BibTeX
@article{Toffaha2025,
author = {Toffaha, Khaled and Simsekler, Mecit Can Emre and Sleptchenko, Andrei and Kortt, Michael A and Bukasa, Laurette L},
title = {A Machine Learning and Bayesian Belief Network Approach to Predicting Cervical Cancer Risk: Implications for Risk Management},
journal = {Journal of Multidisciplinary Healthcare},
year = {2025},
volume = {Volume 18},
pages = {5199--5211},
doi = {10.2147/jmdh.s524132}
}
EUVIMED